IconOVir Bio website screenshot

IconOVir Bio

IconOVir Bio is a New York City-based, clinical-stage life sciences company whose stated mission is to cure cancer and restore life to patients. Backed by GV (Google Ventures) as a portfolio company, IconOVir Bio operates in the oncology and cancer immunotherapy space, developing therapeutics aimed at treating patients across a range of cancers. The company maintains a corporate presence at 689 Fifth Avenue in Manhattan and presents a single-page corporate website with no public developer program, API, SDKs, or technical documentation. This profile was added to the API Evangelist network as a life-sciences portfolio lead; the enrichment pass confirmed there is no public API or developer surface to catalog beyond basic web-domain security posture.

IconOVir Bio is profiled on the APIs.io network. Tagged areas include Company, Life Sciences, Biotechnology, Oncology, and Cancer.

3.3/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-08-20 · rubric v0.12.0
0 APIs
CompanyLife SciencesBiotechnologyOncologyCancerImmunotherapyTherapeutics

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-08-20 · rubric v0.12.0
Composite quality — 3.3/100 · minimal
Contract Quality 0.0 / 21
Developer Ergonomics 0.0 / 17
Access Clarity 0.0 / 17
Operational Transparency 0.0 / 11
Contract Governance 0.0 / 10
Discoverability 4.3 / 9
Regulatory Posture 1.1 / 15
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 10
Documented Reversibility 0 / 6
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
A2A Agent Card 0 / 8
Dry-Run / Simulate Mode 0 / 4
Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.
The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/iconovir-bio: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Iconovir Bio Domain Security

TLSv1.3 · DMARC

SECURITY

Resources

Access & Security 1

Authentication, authorization, and security posture

Company 1

The organization behind the API

Source (apis.yml)

apis.yml Raw ↑
aid: iconovir-bio
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/iconovir-bio.png
name: IconOVir Bio
description: IconOVir Bio is a New York City-based, clinical-stage life sciences company whose stated mission is to cure cancer
  and restore life to patients. Backed by GV (Google Ventures) as a portfolio company, IconOVir Bio operates in the oncology
  and cancer immunotherapy space, developing therapeutics aimed at treating patients across a range of cancers. The company
  maintains a corporate presence at 689 Fifth Avenue in Manhattan and presents a single-page corporate website with no public
  developer program, API, SDKs, or technical documentation. This profile was added to the API Evangelist network as a life-sciences
  portfolio lead; the enrichment pass confirmed there is no public API or developer surface to catalog beyond basic web-domain
  security posture.
url: https://raw.githubusercontent.com/api-evangelist/iconovir-bio/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- gv
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.23'
created: '2026-07-17'
modified: '2026-07-19'
tags:
- Company
- Life Sciences
- Biotechnology
- Oncology
- Cancer
- Immunotherapy
- Therapeutics
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/iconovir-bio-domain-security.yml
- type: Website
  url: https://iconovir.com/
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence